Novellus Closes $57M Series C Financing
09/21/20, 1:07 PM
Location
jerusalemMoney raised
$57 million
Round Type
series c
Novellus, Ltd., a clinical-stage biotechnology company focused on precision oncology announced today that it has raised $57 million in a Series C financing round. The round was led by Pontifax, and joined by OrbiMed Advisors, HBM Healthcare Investments, Wellington Management, Cormorant Asset Management, Novartis Venture Fund (NVF), SR One, as well as existing investors.
Company Info
Location
jerusalem, jerusalem district, israel
Additional Info
Novellus is a clinical-stage drug development company. Novellus focuses on the development of compounds for established oncogene drivers with a high incidence of uncharacterized mutations. Novellus’ leading project, PLX-8394, is in clinical development (NCT02428712).